BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 18781944)

  • 1. Structural bases for substrate and inhibitor recognition by matrix metalloproteinases.
    Aureli L; Gioia M; Cerbara I; Monaco S; Fasciglione GF; Marini S; Ascenzi P; Topai A; Coletta M
    Curr Med Chem; 2008; 15(22):2192-222. PubMed ID: 18781944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis of matrix metalloproteinases and tissue inhibitors of metalloproteinases.
    Maskos K; Bode W
    Mol Biotechnol; 2003 Nov; 25(3):241-66. PubMed ID: 14668538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinase inhibitors: a review on pharmacophore mapping and (Q)SARs results.
    Kontogiorgis CA; Papaioannou P; Hadjipavlou-Litina DJ
    Curr Med Chem; 2005; 12(3):339-55. PubMed ID: 15723623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis of matrix metalloproteinase function.
    Bode W
    Biochem Soc Symp; 2003; (70):1-14. PubMed ID: 14587278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural studies of matrix metalloproteinases.
    Borkakoti N
    J Mol Med (Berl); 2000; 78(5):261-8. PubMed ID: 10954198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis of the matrix metalloproteinases and their physiological inhibitors, the tissue inhibitors of metalloproteinases.
    Bode W; Maskos K
    Biol Chem; 2003 Jun; 384(6):863-72. PubMed ID: 12887053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinases and cancer - roles in threat and therapy.
    Yadav L; Puri N; Rastogi V; Satpute P; Ahmad R; Kaur G
    Asian Pac J Cancer Prev; 2014; 15(3):1085-91. PubMed ID: 24606423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular imaging of matrix metalloproteinases in vivo using small molecule inhibitors for SPECT and PET.
    Wagner S; Breyholz HJ; Faust A; Höltke C; Levkau B; Schober O; Schäfers M; Kopka K
    Curr Med Chem; 2006; 13(23):2819-38. PubMed ID: 17073631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloprotease inhibitors: design from structure.
    Borkakoti N
    Biochem Soc Trans; 2004 Feb; 32(Pt 1):17-20. PubMed ID: 14748704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel strategies to delineate matrix metalloproteinase (MMP)-substrate relationships and identify targets to block MMP activity.
    Lindsey ML
    Mini Rev Med Chem; 2006 Nov; 6(11):1243-8. PubMed ID: 17100635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The design, structure, and therapeutic application of matrix metalloproteinase inhibitors.
    Skiles JW; Gonnella NC; Jeng AY
    Curr Med Chem; 2001 Mar; 8(4):425-74. PubMed ID: 11172697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and functional bases for allosteric control of MMP activities: can it pave the path for selective inhibition?
    Sela-Passwell N; Rosenblum G; Shoham T; Sagi I
    Biochim Biophys Acta; 2010 Jan; 1803(1):29-38. PubMed ID: 19406173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in matrix metalloproteinase research.
    Murphy G; Nagase H
    Mol Aspects Med; 2008 Oct; 29(5):290-308. PubMed ID: 18619669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry.
    Visse R; Nagase H
    Circ Res; 2003 May; 92(8):827-39. PubMed ID: 12730128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Metalloproteinases. Structure and function].
    Lipka D; Boratyński J
    Postepy Hig Med Dosw (Online); 2008 Jul; 62():328-36. PubMed ID: 18614970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinases in vascular physiology and disease.
    Siefert SA; Sarkar R
    Vascular; 2012 Aug; 20(4):210-6. PubMed ID: 22896663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biology of metalloproteinases.
    Amălinei C; Căruntu ID; Bălan RA
    Rom J Morphol Embryol; 2007; 48(4):323-34. PubMed ID: 18060181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinases in the progression of heart failure: potential therapeutic implications.
    Li YY; Feldman AM
    Drugs; 2001; 61(9):1239-52. PubMed ID: 11511020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The design, structure, and clinical update of small molecular weight matrix metalloproteinase inhibitors.
    Skiles JW; Gonnella NC; Jeng AY
    Curr Med Chem; 2004 Nov; 11(22):2911-77. PubMed ID: 15544483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulphonamides: Deserving class as MMP inhibitors?
    Jain P; Saravanan C; Singh SK
    Eur J Med Chem; 2013 Feb; 60():89-100. PubMed ID: 23287054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.